{"id":5192,"date":"2025-02-20T05:41:20","date_gmt":"2025-02-20T05:41:20","guid":{"rendered":"https:\/\/kelingmed.com\/?p=5192"},"modified":"2025-02-25T01:34:10","modified_gmt":"2025-02-25T01:34:10","slug":"global-wheelchair-market-medical-equipment-distribution","status":"publish","type":"post","link":"https:\/\/kelingmed.com\/cs\/global-wheelchair-market-medical-equipment-distribution\/","title":{"rendered":"Hloubkov\u00e1 anal\u00fdza glob\u00e1ln\u00edho trhu s invalidn\u00edmi voz\u00edky: Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed"},"content":{"rendered":"<h2>Hloubkov\u00e1 anal\u00fdza glob\u00e1ln\u00edho trhu s invalidn\u00edmi voz\u00edky: Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed v Africe<\/h2>\n<h3>Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho materi\u00e1lu v Demokratick\u00e9 republice Kongo (DRK)<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><a href=\"\/drc-wheelchair-market-distribution-guide-2025\"><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/drc-wheelchair-market-product-portfolio-2025\/\"><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/drc-wheelchair-demand-drivers-2025\"><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><a href=\"\/drc-wheelchair-regulatory-compliance-guide\/\"><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/drc-wheelchair-import-regulations-tariffs-compliance\"><strong>Import kritick\u00fdch proces\u016f<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/drc-wheelchair-battery-material-compliance\/\"><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><a href=\"\/drc-wheelchair-market-competitive-analysis\"><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/drc-wheelchair-pricing-strategies\/\"><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/drc-wheelchair-market-opportunities\/\"><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><a href=\"\/drc-wheelchair-distribution-channels\/\"><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/drc-wheelchair-ecommerce-strategy\/\"><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/drc-wheelchair-support-services\"><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><a href=\"\/drc-wheelchair-procurement-guide\/\"><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/drc-wheelchair-logistics-guide\"><strong>Optimalizace logistiky<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/drc-wheelchair-risk-management\"><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><a href=\"\/drc-wheelchair-tech-trends-2025\"><strong>Technologick\u00e9 inovace<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/drc-wheelchair-policy-updates-2025\/\"><strong>V\u00fdvoj politiky<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Etiopie Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><a href=\"\/ethiopia-wheelchair-market-analysis-2025\/\"><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/ethiopia-wheelchair-product-analysis-2025\"><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/ethiopia-wheelchair-demand-drivers-2025\"><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><a href=\"\/ethiopia-wheelchair-regulatory-guide-2025\"><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/ethiopia-medical-import-guide-2025\/\"><strong>Import kritick\u00fdch proces\u016f<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/ethiopia-wheelchair-battery-regulations-2025\"><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><a href=\"\/ethiopia-wheelchair-market-competition\/\"><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/ethiopia-wheelchair-pricing-analysis\/\"><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/ethiopia-wheelchair-market-opportunities\/\"><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><a href=\"\/ethiopia-wheelchair-distribution-channels\/\"><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/ethiopia-wheelchair-ecommerce-strategy\/\"><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><a href=\"\/ethiopia-wheelchair-aftersales-rental-analysis\/\"><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/a><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed v Keni<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Nig\u00e9rie Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed v Ji\u017en\u00ed Africe<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>S\u00fad\u00e1n\/Ji\u017en\u00ed S\u00fad\u00e1n Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Uganda Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h2>Hloubkov\u00e1 anal\u00fdza glob\u00e1ln\u00edho trhu s invalidn\u00edmi voz\u00edky: Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed v Asii<\/h2>\n<h3>Afgh\u00e1nist\u00e1n Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Banglad\u00e9\u0161 Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Indon\u00e9sie Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed v Myanmaru<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Filip\u00edny Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed ve Vietnamu<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h2>Hloubkov\u00e1 anal\u00fdza glob\u00e1ln\u00edho trhu s invalidn\u00edmi voz\u00edky: Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed na St\u0159edn\u00edm v\u00fdchod\u011b<\/h2>\n<h3>Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed v Ir\u00e1ku<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed v S\u00fdrii<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed v Jemenu<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h2>Hloubkov\u00e1 anal\u00fdza glob\u00e1ln\u00edho trhu s invalidn\u00edmi voz\u00edky: Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed v Latinsk\u00e9 Americe<\/h2>\n<h3>Braz\u00edlie Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Kolumbie Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Haiti Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed v Mexiku<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h2>Hloubkov\u00e1 anal\u00fdza glob\u00e1ln\u00edho trhu s invalidn\u00edmi voz\u00edky: Evropa a ostatn\u00ed Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h2>\n<h3>Rusko Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Ukrajina Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h3>Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed ve Spojen\u00fdch st\u00e1tech<\/h3>\n<h4><strong>I. P\u0159ehled trhu zem\u011b\/regionu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>\u00dadaje o velikosti trhu (nejnov\u011bj\u0161\u00ed statistiky za rok 2025)<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Ro\u010dn\u00ed objem popt\u00e1vky\/dovozu <\/p>\n<\/li>\n<li>\n<p>Odhady CAGR (2025-2030) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Anal\u00fdza portfolia produkt\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Rozd\u011blen\u00ed pod\u00edlu na trhu: Ru\u010dn\u00ed\/elektrick\u00e9\/sportovn\u00ed invalidn\u00ed voz\u00edky <\/p>\n<\/li>\n<li>\n<p>Segmentace spot\u0159ebitel\u016f: Pr\u00e9miov\u00e9\/st\u0159edn\u00ed\/levn\u00e9 produkty <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Hnac\u00ed s\u00edly popt\u00e1vky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Statistiky st\u00e1rnut\u00ed populace <\/p>\n<\/li>\n<li>\n<p>N\u00e1rodn\u00ed zdravotn\u00ed poji\u0161t\u011bn\u00ed <\/p>\n<\/li>\n<li>\n<p>Stav rozvoje infrastruktury pro osoby se zdravotn\u00edm posti\u017een\u00edm <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>II. R\u00e1mec pro dodr\u017eov\u00e1n\u00ed pr\u00e1vn\u00edch p\u0159edpis\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Klasifika\u010dn\u00ed normy pro zdravotnick\u00e9 prost\u0159edky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>M\u00edstn\u00ed certifika\u010dn\u00ed syst\u00e9my (nap\u0159. FDA 510(k)\/EU MDR). <\/p>\n<\/li>\n<li>\n<p>Ustanoven\u00ed o v\u00fdjimk\u00e1ch z klinick\u00e9ho testov\u00e1n\u00ed <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Import kritick\u00fdch proces\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Celn\u00ed sazby (odkazy na k\u00f3dy HS) <\/p>\n<\/li>\n<li>\n<p>Kontroln\u00ed seznam dokumentace k celn\u00edmu \u0159\u00edzen\u00ed <\/p>\n<\/li>\n<li>\n<p>Po\u017eadavky na lokalizaci (ozna\u010den\u00ed\/jazykov\u00e9 specifikace) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Zvl\u00e1\u0161tn\u00ed omezen\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>P\u0159edpisy pro p\u0159epravu bateri\u00ed <\/p>\n<\/li>\n<li>\n<p>Dodr\u017eov\u00e1n\u00ed po\u017eadavk\u016f na materi\u00e1ly (nap\u0159. REACH\/ROHS) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>III. Mapov\u00e1n\u00ed konkuren\u010dn\u00edho prost\u0159ed\u00ed<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Anal\u00fdza vedouc\u00ed pozice na trhu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Dom\u00e1c\u00ed zna\u010dky (pod\u00edl na trhu + distribu\u010dn\u00ed s\u00edt\u011b) <\/p>\n<\/li>\n<li>\n<p>Strategie pronik\u00e1n\u00ed mezin\u00e1rodn\u00edch zna\u010dek <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Dek\u00f3dov\u00e1n\u00ed cenov\u00e9ho syst\u00e9mu<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Cenov\u00e9 rozmez\u00ed vl\u00e1dn\u00edho tendru <\/p>\n<\/li>\n<li>\n<p>Vzorce p\u0159ir\u00e1\u017eek v maloobchodn\u00edm kan\u00e1lu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Vznikaj\u00edc\u00ed p\u0159\u00edle\u017eitosti<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mezery v popt\u00e1vce po p\u0159izp\u016fsoben\u00ed <\/p>\n<\/li>\n<li>\n<p>Nedostate\u010dn\u00e1 distribuce sekund\u00e1rn\u00edch m\u011bst <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>IV. Hloubkov\u00fd ponor do kan\u00e1lu<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Hlavn\u00ed distribu\u010dn\u00ed modely<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Mechanismy p\u0159\u00edm\u00e9ho prodeje v nemocnic\u00edch <\/p>\n<\/li>\n<li>\n<p>Procesy zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek v rehabilita\u010dn\u00edm centru <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Strategie elektronick\u00e9ho obchodov\u00e1n\u00ed<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>3 nejlep\u0161\u00ed m\u00edstn\u00ed platformy B2B <\/p>\n<\/li>\n<li>\n<p>Krit\u00e9ria pro v\u00fdb\u011br p\u0159eshrani\u010dn\u00ed platformy <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Pot\u0159eby dopl\u0148kov\u00fdch slu\u017eeb<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Standardy v\u00fdstavby poprodejn\u00ed s\u00edt\u011b <\/p>\n<\/li>\n<li>\n<p>Anal\u00fdza proveditelnosti pron\u00e1jmu invalidn\u00edch voz\u00edk\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>V. Doporu\u010den\u00ed ke strategii zad\u00e1v\u00e1n\u00ed ve\u0159ejn\u00fdch zak\u00e1zek<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Matice prov\u011b\u0159ov\u00e1n\u00ed dodavatel\u016f<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Srovn\u00e1n\u00ed n\u00e1klad\u016f: \u010c\u00edn\u0161t\u00ed v\u00fdrobci vs. m\u00edstn\u00ed dodavatel\u00e9 <\/p>\n<\/li>\n<li>\n<p>KPI pro audit kvality (nap\u0159. certifikace ISO 7176) <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Optimalizace logistiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>V\u00fdpo\u010dty prahov\u00fdch hodnot n\u00e1klad\u016f FCL\/LCL <\/p>\n<\/li>\n<li>\n<p>Strategie nasazen\u00ed v\u00e1zan\u00fdch sklad\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>\u0158\u00edzen\u00ed rizik<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Historie antidumpingov\u00e9ho \u0161et\u0159en\u00ed <\/p>\n<\/li>\n<li>\n<p>Zm\u00edrn\u011bn\u00ed v\u00fdkyv\u016f sm\u011bnn\u00fdch kurz\u016f <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>\n<h4><strong>VI. Sledov\u00e1n\u00ed nov\u00fdch trend\u016f<\/strong><\/h4>\n<ol>\n<li>\n<p><strong>Technologick\u00e9 inovace<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aplikace inteligentn\u00edho syst\u00e9mu proti p\u0159evr\u00e1cen\u00ed <\/p>\n<\/li>\n<li>\n<p>Pokrok v zav\u00e1d\u011bn\u00ed materi\u00e1l\u016f z uhl\u00edkov\u00fdch vl\u00e1ken <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>V\u00fdvoj politiky<\/strong><\/p>\n<ul data-mark=\"-\">\n<li>\n<p>Aktualizace vl\u00e1dn\u00edch dotac\u00ed <\/p>\n<\/li>\n<li>\n<p>Posouzen\u00ed intenzity politiky substituce dovozu <\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<hr \/>","protected":false},"excerpt":{"rendered":"<p>Hloubkov\u00e1 anal\u00fdza glob\u00e1ln\u00edho trhu s invalidn\u00edmi voz\u00edky: Kon\u017esk\u00e1 demokratick\u00e1 republika (KDR) Pr\u016fvodce distribuc\u00ed zdravotnick\u00e9ho vybaven\u00ed v Africe<\/p>","protected":false},"author":1,"featured_media":5241,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[43],"tags":[],"class_list":["post-5192","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-wheelchair"],"amp_enabled":false,"_links":{"self":[{"href":"https:\/\/kelingmed.com\/cs\/wp-json\/wp\/v2\/posts\/5192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kelingmed.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kelingmed.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kelingmed.com\/cs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kelingmed.com\/cs\/wp-json\/wp\/v2\/comments?post=5192"}],"version-history":[{"count":55,"href":"https:\/\/kelingmed.com\/cs\/wp-json\/wp\/v2\/posts\/5192\/revisions"}],"predecessor-version":[{"id":5482,"href":"https:\/\/kelingmed.com\/cs\/wp-json\/wp\/v2\/posts\/5192\/revisions\/5482"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kelingmed.com\/cs\/wp-json\/wp\/v2\/media\/5241"}],"wp:attachment":[{"href":"https:\/\/kelingmed.com\/cs\/wp-json\/wp\/v2\/media?parent=5192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kelingmed.com\/cs\/wp-json\/wp\/v2\/categories?post=5192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kelingmed.com\/cs\/wp-json\/wp\/v2\/tags?post=5192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}